Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Efficacy and Safety of a Proposed Omalizumab Biosimilar Compared to the Reference Product in the Management of Uncontrolled Moderate-To-Severe Allergic Asthma: A Multicenter, Phase Iii, Randomized, Double-Blind, Equivalency Clinical Trial
Nafiseh Esmaeil
Nafiseh Esmaeil

Associate Professor of Medical Immunology

Department of Immunology, School of Medicine

Child Growth and Development Research Center

Research Institute for Primordial Prevention of Non-communicable Disease

Isfahan University of Medical Sciences

Related Documents
All Documents